378 related articles for article (PubMed ID: 24815828)
1. Post-translational histone modifications in circulating nucleosomes as new biomarkers in colorectal cancer.
Gezer U; Holdenrieder S
In Vivo; 2014; 28(3):287-92. PubMed ID: 24815828
[TBL] [Abstract][Full Text] [Related]
2. Histone Methylation Marks on Circulating Nucleosomes as Novel Blood-Based Biomarker in Colorectal Cancer.
Gezer U; Yörüker EE; Keskin M; Kulle CB; Dharuman Y; Holdenrieder S
Int J Mol Sci; 2015 Dec; 16(12):29654-62. PubMed ID: 26690425
[TBL] [Abstract][Full Text] [Related]
3. Age-dependent clinical prognostic value of histone modifications in colorectal cancer.
Goossens-Beumer IJ; Benard A; van Hoesel AQ; Zeestraten EC; Putter H; Böhringer S; Liefers GJ; Morreau H; van de Velde CJ; Kuppen PJ
Transl Res; 2015 May; 165(5):578-88. PubMed ID: 25488396
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic biomarkers in colorectal cancer diagnostics.
Rawson JB; Bapat B
Expert Rev Mol Diagn; 2012 Jun; 12(5):499-509. PubMed ID: 22702366
[TBL] [Abstract][Full Text] [Related]
5. Epigenetics of colorectal cancer.
Migheli F; Migliore L
Clin Genet; 2012 Apr; 81(4):312-8. PubMed ID: 22263639
[TBL] [Abstract][Full Text] [Related]
6. Histone modifications as a pathogenic mechanism of colorectal tumorigenesis.
Gargalionis AN; Piperi C; Adamopoulos C; Papavassiliou AG
Int J Biochem Cell Biol; 2012 Aug; 44(8):1276-89. PubMed ID: 22583735
[TBL] [Abstract][Full Text] [Related]
7. The role of epigenetics in colorectal cancer.
Coppedè F
Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):935-48. PubMed ID: 24871610
[TBL] [Abstract][Full Text] [Related]
8. Novel serum nucleosomics biomarkers for the detection of colorectal cancer.
Holdenrieder S; Dharuman Y; Standop J; Trimpop N; Herzog M; Hettwer K; Simon K; Uhlig S; Micallef J
Anticancer Res; 2014 May; 34(5):2357-62. PubMed ID: 24778043
[TBL] [Abstract][Full Text] [Related]
9. SILAC-based proteomic analysis to dissect the "histone modification signature" of human breast cancer cells.
Cuomo A; Moretti S; Minucci S; Bonaldi T
Amino Acids; 2011 Jul; 41(2):387-99. PubMed ID: 20617350
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation and colorectal cancer.
Matsubara N
Dis Colon Rectum; 2012 Jan; 55(1):96-104. PubMed ID: 22156874
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic biomarkers in colorectal cancer: premises and prospects.
Zamani M; Hosseini SV; Mokarram P
Biomarkers; 2018 Mar; 23(2):105-114. PubMed ID: 27788596
[TBL] [Abstract][Full Text] [Related]
12. Interplay between different epigenetic modifications and mechanisms.
Murr R
Adv Genet; 2010; 70():101-41. PubMed ID: 20920747
[TBL] [Abstract][Full Text] [Related]
13. Relevance of histone marks H3K9me3 and H4K20me3 in cancer.
Leszinski G; Gezer U; Siegele B; Stoetzer O; Holdenrieder S
Anticancer Res; 2012 May; 32(5):2199-205. PubMed ID: 22593510
[TBL] [Abstract][Full Text] [Related]
14. A novel proteomics approach to epigenetic profiling of circulating nucleosomes.
Van den Ackerveken P; Lobbens A; Turatsinze JV; Solis-Mezarino V; Völker-Albert M; Imhof A; Herzog M
Sci Rep; 2021 Mar; 11(1):7256. PubMed ID: 33790358
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation by histone methylation and histone variants.
Cheung P; Lau P
Mol Endocrinol; 2005 Mar; 19(3):563-73. PubMed ID: 15677708
[TBL] [Abstract][Full Text] [Related]
16. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic biomarkers of colorectal cancer: Focus on DNA methylation.
Coppedè F
Cancer Lett; 2014 Jan; 342(2):238-47. PubMed ID: 22202641
[TBL] [Abstract][Full Text] [Related]
18. Histone onco-modifications.
Füllgrabe J; Kavanagh E; Joseph B
Oncogene; 2011 Aug; 30(31):3391-403. PubMed ID: 21516126
[TBL] [Abstract][Full Text] [Related]
19. A modified epigenetics toolbox to study histone modifications on the nucleosome core.
Frederiks F; Stulemeijer IJ; Ovaa H; van Leeuwen F
Chembiochem; 2011 Jan; 12(2):308-13. PubMed ID: 21243718
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets.
Herranz M; Esteller M
Methods Mol Biol; 2007; 361():25-62. PubMed ID: 17172706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
